Pharmaceutical and healthcare information provider IMS Health, US, has named Adel Al-Saleh as senior vice president, Sales and Global Account Management. Previously, Al-Saleh was president, Europe, Middle East and Africa for IMS. He will continue to report to IMS chairman and CEO, David Carlucci.
In his new position, Al-Saleh will be responsible for advancing the company's go-to-market initiatives, working closely with the sales, consulting, services and business line organisations to ensure a consistent, globally integrated approach to client engagement. In his new role, he will bring together IMS's full continuum of information, analytics, consulting and services to help clients gain a deeper understanding of market dynamics as they shape new business models and strategies. Al-Saleh will also oversee the company's Global Key Account Management efforts, driving sales activities with multinational clients.
The company also announced that Seyed Mortazavi has been appointed president, EMEA, reporting to Carlucci. He assumes responsibility for IMS operations in more than 50 countries in Europe, the Middle East and Africa. During his 14 years at IMS, Mortazavi has held roles of increasing responsibility in the U.K., U.S., and EMEA sales organisations. Most recently, he served as general manager, UK, Ireland and South Africa.
Get customisable STM news alerts in your Mobile. Visit http://www.scopeknowledge.com/scoope.jar via your mobile browser to download the SCOOPE application
